Here are six key notes from the second quarter financial report:
1. The orthopedics sales worldwide was $2.3 billion, up 1.1 percent from the same period last year. The United States sales hit $1.3 billion — a 3 percent growth — while international sales dropped 1.8 percent to $991 million.
2. Hip sales in the United States grew 2.1 percent to $197 million while international sales jumped 6.3 percent to $152 million. Worldwide hip sales hit $349 million — a 3.9 percent increase.
3. Knee sales saw a slight increase — 3.5 percent — worldwide to hit $385 million. In the United States, knee sales were up 3.2 percent to $229 million and international sales were up 4 percent to $156 million.
4. Spine and other sales were $985 million worldwide, a 1.6 percent drop driven by a 4 percent drop in international sales. Spine and other sales in the United States were up 0.4 percent to $557 million.
5. Trauma sales dropped 5.6 percent worldwide, hitting only $255 million. However, trauma sales were up 8.5 percent in the United States to $381 million and showed a 2.4 percent growth overall to $637 million.
6. The company also reported six month results:
• Hip sales: $691 million, 3.3 percent growth
• Knee sales: $774 million, 3.5 percent growth
• Trauma sales: $1.2 billion, 0.1 percent growth
• Spine and other sales: $1.2 billion, 0.1 percent growth
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
